DermTech Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2016
Revenue	15.3	14.52	11.84	5.89	3.36	2.44	0
Revenue Growth (YoY)	5.36%	22.64%	101.16%	74.94%	37.76%	-	-
Cost of Revenue	15.02	13.87	10.56	5.98	3.3	2.63	0
Gross Profit	0.28	0.65	1.27	-0.1	0.06	-0.19	0
Selling, General & Admin	88.78	94.76	62.41	29.9	15.17	6.32	0
Research & Development	15.24	24.05	16.26	5.29	2.5	2.05	0
Other Operating Expenses	0	0	0	0	0	0	0
Operating Expenses	104.02	118.81	78.67	35.19	17.67	8.38	0
Operating Income	-103.74	-118.17	-77.4	-35.29	-17.61	-8.56	-0
Interest Expense / Income	0	0	0	0	0	1.09	0
Other Expense / Income	-2.85	-1.48	0.94	1.19	2.53	0.35	-
Pretax Income	-100.89	-116.68	-78.34	-36.48	-20.13	-10	-0
Net Income	-100.89	-116.68	-78.34	-36.48	-20.13	-10	-0
Shares Outstanding (Basic)	33	30	29	17	7	4	2
Shares Outstanding (Diluted)	33	30	29	17	7	4	2
Shares Change	8.66%	4.00%	70.12%	142.39%	58.81%	135.25%	-
EPS (Basic)	-3.09	-3.88	-2.71	-2.15	-2.87	-2.27	-
EPS (Diluted)	-3.09	-3.88	-2.71	-2.15	-2.87	-2.27	-
Free Cash Flow	-77.88	-98.57	-64.83	-30.52	-18	-7.62	0
Free Cash Flow Per Share	-2.39	-3.28	-2.24	-1.80	-2.57	-1.73	0.00
Gross Margin	1.80%	4.46%	10.76%	-1.63%	1.78%	-7.58%	-
Operating Margin	-678.21%	-813.92%	-653.81%	-599.64%	-523.34%	-350.53%	-
Profit Margin	-659.57%	-803.71%	-661.72%	-619.83%	-598.39%	-409.66%	-
Free Cash Flow Margin	-509.16%	-678.92%	-547.61%	-518.57%	-535.11%	-311.92%	-
EBITDA	-95.04	-112.22	-76.04	-35.99	-20.04	-8.84	-0
EBITDA Margin	-621.35%	-772.99%	-642.33%	-611.57%	-595.75%	-361.79%	-
Depreciation & Amortization	5.85	4.46	2.3	0.49	0.09	0.08	0
EBIT	-100.89	-116.68	-78.34	-36.48	-20.13	-8.91	-0
EBIT Margin	-659.57%	-803.71%	-661.72%	-619.83%	-598.39%	-364.91%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).